Stay updated on MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page.

Latest updates to the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe revision label on the page was updated from v3.6.3 to v3.6.4, indicating a software release update for the page. The change is a backend version bump rather than content or data changes on the page.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now shows Revision: v3.6.3 as the current document version and no longer shows Revision: v3.6.1. This indicates an updated protocol/document is available for reference.SummaryDifference0.0%

- Check50 days agoChange DetectedRecruitment status updated to indicate enrollment is closed. New help/navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading formatting was adjusted.SummaryDifference0.3%

- Check57 days agoChange DetectedThe page's revision label changed from v3.5.4 to v3.5.5, indicating a minor update to the page's version history without altering displayed content.SummaryDifference0.0%

- Check79 days agoChange DetectedPage revision tag updated to v3.5.4, replacing the previous v3.5.3. This indicates an updated version of the page content in the site's revision history.SummaryDifference0.0%

- Check93 days agoChange DetectedThe Taiwan study site address changed from Taoyuan District, Taiwan, 333 to Taoyuan, Taiwan, 333, updating the city designation in the location listing.SummaryDifference0.0%

Stay in the know with updates to MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page.